IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 223 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 0.15 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $4 | -33.3% | 877 | 0.0% | 0.00% | – |
Q2 2023 | $6 | +20.0% | 877 | 0.0% | 0.00% | – |
Q1 2023 | $5 | +25.0% | 877 | +49.7% | 0.00% | – |
Q4 2022 | $4 | -99.9% | 586 | 0.0% | 0.00% | – |
Q3 2022 | $6,000 | 0.0% | 586 | 0.0% | 0.00% | – |
Q2 2022 | $6,000 | -25.0% | 586 | +27.9% | 0.00% | – |
Q1 2022 | $8,000 | -11.1% | 458 | 0.0% | 0.00% | – |
Q4 2021 | $9,000 | -30.8% | 458 | -13.7% | 0.00% | – |
Q3 2021 | $13,000 | +62.5% | 531 | +82.5% | 0.00% | – |
Q2 2021 | $8,000 | -11.1% | 291 | 0.0% | 0.00% | – |
Q1 2021 | $9,000 | -30.8% | 291 | +5.4% | 0.00% | – |
Q4 2020 | $13,000 | -51.9% | 276 | -66.3% | 0.00% | – |
Q3 2020 | $27,000 | +28.6% | 819 | +15.0% | 0.00% | – |
Q2 2020 | $21,000 | 0.0% | 712 | 0.0% | 0.00% | – |
Q1 2020 | $21,000 | +5.0% | 712 | 0.0% | 0.00% | – |
Q4 2019 | $20,000 | +42.9% | 712 | -9.3% | 0.00% | – |
Q3 2019 | $14,000 | -26.3% | 785 | 0.0% | 0.00% | – |
Q2 2019 | $19,000 | +171.4% | 785 | 0.0% | 0.00% | – |
Q1 2019 | $7,000 | +75.0% | 785 | +95.8% | 0.00% | – |
Q4 2018 | $4,000 | -20.0% | 401 | 0.0% | 0.00% | – |
Q3 2018 | $5,000 | 0.0% | 401 | 0.0% | 0.00% | – |
Q2 2018 | $5,000 | -28.6% | 401 | 0.0% | 0.00% | – |
Q1 2018 | $7,000 | – | 401 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Fairmount Funds Management LLC | 565,890 | $26,257,000 | 9.39% |
Consonance Capital Management LP | 1,710,803 | $79,381,000 | 7.41% |
GREAT POINT PARTNERS LLC | 917,427 | $42,569,000 | 6.91% |
Avoro Capital Advisors LLC | 7,500,000 | $348,000,000 | 5.99% |
Ghost Tree Capital, LLC | 500,000 | $23,200,000 | 5.17% |
FRAZIER MANAGEMENT LLC | 1,312,999 | $60,923,000 | 4.69% |
Perceptive Advisors | 9,166,304 | $425,316,000 | 4.56% |
Ally Bridge Group (NY) LLC | 360,000 | $16,704,000 | 2.86% |
Orbimed Advisors | 6,645,100 | $308,333,000 | 2.70% |
ACUTA CAPITAL PARTNERS, LLC | 164,800 | $7,647,000 | 2.08% |